Our fifth of 10 webinars, the American Thyroid Association invites you to join us for our summer series of thyroid education. Programming from the ATA Personalized Approach to Thyroid Disorders and Controversies in Thyroidology cancelled 2020 in-person meetings due to COVID-19 have been transitioned into virtual programs. Learn from leading experts and earn CME and MOC credit all from the comfort of your home or office.
This course includes a live Q&A session with faculty. Join the July 14, 2020 2:00 PM ET broadcast to be a part of the live Q&A session or post July 14 watch the program on-demand and receive 1.0 credit until August 31, 2021. View the Accreditation Statement/Credit tab for additional details.
Moderators: Whitney S. Goldner, MD and Kepal Patel, MD
Ethanol Ablation for Benign and Malignant Thyroid Disease (Juan P. Brito Campana, MD, MSc)
Discuss the practical and technical aspects of percutaneous ethanol injection for thyroid pathology.
Recognize which patients may benefit from percutaneous ethanol injection.
Controversies: Radiofrequency Ablation for Thyroid Disease (Steven P. Hodak, MD)
Understand indications for appropriate use of radiofrequency ablation for treatment of thyroid diseases
Understand the potential treatment risks associated with radiofrequency ablation of thyroid tumors
Register for the full series of 10 webinars and save on registration fees. To learn more about the webinar series, faculty, accreditation details, program committees, pricing and more, visit the ATA website at https://www.thyroid.org/2020-virtual-program-library/.
American Thyroid Association virtual programs are open to all healthcare professionals who wish to broaden and update their knowledge of the thyroid gland and thyroid cancer. ATA content is scientific in nature and is intended for researchers and practitioners in thyroidology with interests in the fields of endocrinology, oncology, nuclear medicine, internal medicine, surgery, pathology, radiation oncology, cytology, biology, pharmacology, family medicine and related areas. ATA education is targeted to the full thyroid team who diagnose and treat thyroid disorders (e.g., primary care physicians, nurse practitioners, registered nurses, physician assistants, etc.).
Steven P. Hodak, MD specializes in thyroid cancer and molecular diagnostics. Dr. Hodak received his medical degree from Georgetown University School of Medicine where he also completed residency training in Internal Medicine, served as Chief Medical Resident and completed fellowship training in Endocrinology and Metabolism. After serving as the Co-Director of the Endocrine Tumor Center at the University of Pittsburgh, he was recruited to NYU Langone Medical Center in 2014. Dr. Hodak is a Professor of Medicine at the NYU School of Medicine and serves as the Associate Director for Clinical Affairs for the Division of Endocrinology, Diabetes and Metabolism; Director of the Faculty Group Practice; and as Section Chief of Endocrinology at NYU Langone Tisch Hospital. Dr. Hodak is board-certified in Endocrinology.
Juan P. Brito Campana, MD, MSc is an endocrinologist, health care researcher, medical director of the Mayo Clinic Shared Decision Making National Resource Center and principal investigator in the Knowledge and Evaluation Research Unit (KER). Dr. Brito focuses on understanding trends and patterns of care for patients with thyroid nodules and thyroid cancer.
Kepal N. Patel, MD is the Chief of the Division of Endocrine Surgery and an Associate Professor of Surgery, Otolaryngology and Biochemistry at NYU Langone Medical Center. He is the Director of the Thyroid Interdisciplinary Program and has particular expertise in the multidisciplinary treatment of Thyroid and Parathyroid disease along with other head and neck tumors. He also leads the translational research program for the Division of Endocrine Surgery. Dr. Patel has been studying the molecular pathogenesis of thyroid carcinoma by focusing on the changes in intracellular pathways that lead to the progression of thyroid cancer. His research interests also include studying the relationship of autoimmune thyroiditis to thyroid cancer at the genomic level.
He earned his M.D. from UMDNJ-Robert Wood Johnson Medical School and completed his Oncologic Head and Neck Surgery training at Memorial Sloan-Kettering Cancer Center. Dr. Patel’s work has been recognized by numerous awards from prestigious societies such as the American Society of Clinical Oncology, American Head and Neck Society, American Association of Endocrine Surgeons, and the American Thyroid Association. He currently serves in multiple leadership roles both locally and nationally and is a reviewer and on the editorial board of several journals.
Whitney Goldner, MD is an Endocrinologist at the University of Nebraska Medical Center, Omaha, NE. She is an Associate Professor of Medicine in the Division of Diabetes, Endocrinology, and Metabolism, Dept of Internal Medicine. She is the PI of ICaRe2, which is a bioinformatics registry and biospecimen bank at UNMC for thyroid nodules and thyroid cancer. She specializes in thyroid disease, thyroid nodules, and thyroid cancer as well as neuroendocrine tumors and other Endocrine disorders. She is the Endocrinology Fellowship Program director and runs the thyroid ultrasound and biopsy clinics.